Strongbridge Biopharma plc SBBP
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 135.66M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -11.76
- Beta
- 1.60
- Short ratio
- 1.40
- Inst. own
- 63.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2021
- 50-d avg
- 2.14
- 200-d avg
- 2.48
- 1y target
- 5.00
News
5 years ago businesswire.com
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable…
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the…
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the…
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that its shareholders have voted to…
5 years ago globenewswire.com
Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Glass Lewis Joins ISS in Recommending Strongbridge Shareholders Vote “FOR” Transaction with Xeris
5 years ago globenewswire.com
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Strongbridge Urges Shareholders to Vote “FOR” All Transaction-Related Proposals Strongbridge Urges Shareholders to Vote “FOR” All Transaction-Related Proposals
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows.
5 years ago zacks.com
Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates
Strongbridge Biopharma (SBBP) delivered earnings and revenue surprises of 20.00% and 13.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
5 years ago globenewswire.com
Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update
~ Reports KEVEYIS ® (dichlorphenamide) Second Quarter 2021 Revenue of $10.0 Million, a 28 Percent Increase Compared to $7.8 Million of Revenue During Second Quarter of 2020 ~
-
5 years ago benzinga.com
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy Statement
DUBLIN, Ireland and TREVOSE, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP) (“Strongbridge”), a global commercial-stage biopharmaceutical company focused on the…
5 years ago globenewswire.com
Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP) (“Strongbridge”), a global commercial-stage biopharmaceutical company focused on the…
5 years ago globenewswire.com
Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021
DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and…
5 years ago zacks.com
Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Strongbridge Biopharma (SBBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve
~ Study Confirms Long-Term Treatment with KEVEYIS is Safe and Effective for Chronic Use ~
5 years ago globenewswire.com
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing's Syndrome
DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and…
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Strongbridge Biopharma plc - SBBP
NEW YORK, May 29, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
5 years ago businesswire.com
STRONGBRIDGE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Strongbridge Biopharma plc - SBBP
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Strongbridge…
5 years ago businesswire.com
Strongbridge Biopharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Strongbridge Biopharma plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SBBP
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Strongbridge Biopharma plc (NASDAQ: SBBP) to Xeris Pharmaceuticals, Inc. is fair…
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Investigates Strongbridge Biopharma plc
NEW YORK, May 24, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Strongbridge Biopharma plc…
-
5 years ago benzinga.com
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.
-
5 years ago benzinga.com
Earnings Scheduled For March 3, 2021
Companies Reporting Before The Bell • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.
-
6 years ago benzinga.com
Earnings Scheduled For October 29, 2020
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 144 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 118 companies set new 52-week highs.
-
6 years ago benzinga.com
55 Stocks Moving In Monday's Mid-Day Session
55 Stocks Moving In Monday's Mid-Day Session
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
7 years ago benzinga.com
41 Stocks Moving In Monday's Mid-Day Session
41 Stocks Moving In Monday's Mid-Day Session
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 17th
Stocks Which Set New 52-Week Low Yesterday, September 17th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, September 14
Stocks Which Set New 52-Week Low Friday, September 14